关于 Ginkgo Bioworks, Inc.
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
Source: Wikipedia
总部27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA 02210
成立2008
法律形式C Corporation
状态营业中
专利289 项专利
INCREASED NITROGEN FIXATION USING BACTERIA WITH IMPROVED AMMONIA SECRETIONUS20260201315A1 · 2026
Scalable, mobile, and reconfigurable modules for processing biological and chemical materialsUS12674810B2 · 2026
关键数据
法律信息
| 法定名称 | Ginkgo Bioworks, Inc. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1648827在 SEC EDGAR 上查看 ↗ |
| EIN | 26-3118890 |
| 注册地址 | 27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA 02210 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026
联系方式和链接
地点
27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA 02210
这是你的公司吗?
免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。
认领此页面